Fact: Employers are under no obligation to hire pharmacy benefit companies, but a vast majority of employers work with pharmacy benefit companies. Recent findings from the PricewaterhouseCoopers (PwC) 2021 “Health and Well-being Touchstone Survey” of 368 companies explains why employers,
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing, “The Need to Make Insulin Affordable for All Americans,”
Legislation Would Limit Options for Employers to Provide Quality Prescription Drug Coverage for Employees The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee is weighing several proposed policies related to the prescription drug market, including S. 1339, the Pharmacy
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott joined other organization and company CEOs to sign the CEO Action Pledge supporting more diversity and inclusion within the workplace. The CEO pledge outlines a specific set of actions
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription drug costs for patients and health plan sponsors. PBMs administer prescription drug plans for more than 266 million Americans with
This week, the U.S. House Committee on the Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust held a hearing on pharmacy benefit managers (PBMs), where expert witnesses and members of the committee highlighted the critical role of PBMs
Glossary of Drug Pricing Terms Abbreviations Acronym Full Phrase AAC Actual Acquisition Cost or Average Acquisition Cost ACA Affordable Care Act AMP Average Manufacturer Price ASP Average Sales Price AWP Average Wholesale Price or Any Willing Pharmacy BER Brand Effective
In case you missed it, Ryan Costello, former U.S. Representative (R-PA-06), urged Members of Congress to focus on solutions to stop Big Pharma’s patent abuse in a recent RealClearHealth op-ed. Costello also urges lawmakers to oppose misguided policies targeting pharmacy
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on today’s article in The New York Times. “Today’s article from The New York Times fundamentally misconstrues the critical value of pharmacy benefit
Jonathan Heafitz Vice President of Federal Affairs Jonathan Heafitz is the Vice President of Federal Affairs for the Pharmaceutical Care Management Association (PCMA). In this capacity, Heafitz oversees PCMA’s advocacy at the federal level on behalf of America’s pharmacy benefit
©2024 PCMA. All Rights Reserved.
